Chart2020 Duo app gets enhanced features

Article

Konan’s Chart2020 Duo app has a new media library enhancement released for the iPad. The media library is available for a limited time at an introductory price from the Apple iTunes Store.

Konan’s Chart2020 Duo app has a new media library enhancement released for the iPad. The media library is available for a limited time at an introductory price from the Apple iTunes Store. The first release of the media library includes patient-friendly illustrations and videos on a wide range of eye disease and surgery topics such as macular degeneration, refractive surgery, cataract surgery, color vision/color blindness, diabetic retinopathy, endothelial dystrophies, and more. The Media Library was developed to be extensible with future versions allowing third-party images and other educational features.

The Chart2020 Duo app provides a framework for near and intermediate distance visual performance testing. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
© 2025 MJH Life Sciences

All rights reserved.